The death of Susan McGowan, a 58-year-old nurse from North Lanarkshire, has been linked to the weight-loss medication tirzepatide, branded as Mounjaro. After taking two low-dose injections, McGowan experienced severe health complications leading to organ failure and septic shock, making her death the first officially associated with the drug in the UK. As the Medicines and Healthcare products Regulatory Agency assures safety monitoring, experts emphasize the need for cautious evaluations of new medications. The case highlights growing scrutiny around the safety of weight-loss drugs amidst their rising use.